本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

0.5751
-0.0388-6.32%
盤前0.5595-0.0156-2.71%05:18 EDT
成交量:25.29萬
成交額:14.76萬
市值:349.71萬
市盈率:-4.24
高:0.6000
開:0.6000
低:0.5600
收:0.6139
52周最高:2.79
52周最低:0.5600
股本:608.09萬
流通股本:501.95萬
量比:1.00
換手率:5.04%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
淨資產收益率:-1708.61%
總資產收益率:-22.79%
市淨率:0.82
市盈率(LYR):-4.24

資料載入中...

2021/01/11

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/11

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/27

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/05

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]